Research Articles | Page 82 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Content validity of patient-reported outcomes for use in lower-risk myelodysplastic syndromes Aug 2020 Journal of Patient-Reported Outcomes myelodysplastic syndromes (MDS)
Ocular complications in a young pediatric population following bone marrow transplantation Jan 2018 Journal of the American Academy of Pediatric Oncology and Strabsimus aplastic anemia
Progress in the Management of Pregnancy with Paroxysmal Nocturnal Hemoglobinuria: A Review Jan 2024 Journal of Women's Health paroxysmal nocturnal hemoglobinuria (PNH)
A Primary Care Approach to Myelodysplastic Syndromes May 2014 Korean J Fam Med myelodysplastic syndromes (MDS)
Are we ready to ring in a new upfront therapy in lower-risk myelodysplastic syndromes? Jun 2023 Lancet myelodysplastic syndromes (MDS)
Are we ready to ring in a new upfront therapy in lower-risk myelodysplastic syndromes? Jul 2023 Lancet myelodysplastic syndromes (MDS)
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial Jun 2023 Lancet myelodysplastic syndromes (MDS)
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial Jan 2024 Lancet myelodysplastic syndromes (MDS)
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial Jul 2023 Lancet myelodysplastic syndromes (MDS)
Myelodysplastic syndromes Mar 2014 Lancet myelodysplastic syndromes (MDS)
Share with addtoany.com.